Farmas USA

ya, ya me estoy cagando en los cáncamos de la lápida del señor por no poner la orden el otro día :)

Estamos con el IBB en +0,85% ... como cierre hoy en tan solo +1% seria fin de mes y comienzo del cole la proxima semana en maximos historicos. Menudas velas semanal y mensual! VAYA VERANITO!!!!

Por cierto, lo del techo de deuda y todo la mandanga esa por la que nos hacen pasar cada año, eso es en Octubre, no?

NVAX Parece que ya ha cerrado ese hueco que estaba por cerrar en 4,56.

Esta semana en velas 1h. 

NVAX :)

pt

pues está para que la próxima semana te pongas en verde, esos 2.04 de premarket parece que era la entrada, solo faltaba un par de canicas para darle al dedo.

THLD
la novia madurita un tanto seca, el martes esperemos le proporcionen algo de lubricante.

El destino de Amarin lo va a decidir este tipo

https://www.youtube.com/watch?v=QuttNcrypEE&feature=youtu.be

si es otro jo'puta o no esta por ver ...

Dr. Jenkins is currently the Director of the Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration. Dr. Jenkins received his undergraduate degree in biology from East Tennessee State University in 1979 and his medical degree from the University of Tennessee at Memphis in 1983. Dr. Jenkins completed his postgraduate medical training in internal medicine, pulmonary disease, and critical care medicine at Virginia Commonwealth University/Medical College of Virginia from 1983 until 1988. Dr. Jenkins is Board Certified in Internal Medicine and Pulmonary Diseases by the American Board of Internal Medicine. Dr. Jenkins is also a Fellow of the American College of Chest Physicians. Following completion of his medical training, Dr. Jenkins joined the faculty of MCV as an Assistant Professor of Pulmonary and Critical Care Medicine and as a Staff Physician at the McGuire VA Medical Center in Richmond. Dr. Jenkins joined FDA as a medical officer in the Division of Oncology and Pulmonary Drug Products in 1992. He subsequently served as Pulmonary Medical Group Leader and Acting Division Director before being appointed as Director of the newly created Division of Pulmonary Drug Products in 1995. Dr. Jenkins became the Director of the Office of Drug Evaluation II in 1999 and served in that position until he was appointed to his current position in January 2002.

En 10 años a la cuspide....este es carne de soborno,le mandamos unos jamones?